DNA methylation and expression patterns of selected genes in first-trimester placental tissue from pregnancies with small-for-gestational-age infants at birth

Biology of Reproduction

Volumn 94, Issue 2, 2016, Pages

  Leeuwerke, Mariëtte ^a   Eilander, Michelle S ^a   Pruis, Maurien G M ^a   Lendvai, Ágnes ^a   Erwich, Jan Jaap H M ^a   Scherjon, Sicco A ^a   Plösch, Torsten ^a   Eijsink, Jasper J H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Epigenetics; FGR; IUGR; Methylation; Placenta; SGA

Indexed keywords

SOMATOMEDIN B; WNT2 PROTEIN; IGF2 PROTEIN, HUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SERINE PROTEINASE INHIBITOR; SERPINA3 PROTEIN, HUMAN;

ADULT; ARTICLE; BIRTH WEIGHT; CHORION VILLUS SAMPLING; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MALE; MATERNAL AGE; PARITY; PLACENTA DISORDER; PLACENTA TISSUE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT; TRANSCRIPTION INITIATION SITE; CASE CONTROL STUDY; GENETICS; METABOLISM; NEWBORN; PLACENTA; PREGNANCY; RETROSPECTIVE STUDY;

CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR II; PLACENTA; PPAR GAMMA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RETROSPECTIVE STUDIES; SERPINS; WNT2 PROTEIN;

EID: 84961208606     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.115.131698     Document Type: Article

References (40)

1. Novakovic B, Saffery R. The ever growing complexity of placental epigenetics-role in adverse pregnancy outcomes and fetal programming. Placenta 2012;33:959-970
2. Nelissen EC, van Montfoort AP, Dumoulin JC, Evers JL. Epigenetics and the placenta. Hum Reprod Update 2011;17:397-417
3. Koukoura O, Sifakis S, Spandidos DA. DNA methylation in the human placenta and fetal growth (review). Mol Med Report 2012;5:883-889
4. Unterscheider J, Daly S, Geary MP, Kennelly MM, McAuliffe FM, O'Donoghue K, Hunter A, Morrison JJ, Burke G, Dicker P, Tully EC, Malone FD. Definition and management of fetal growth restriction: a survey of contemporary attitudes. Eur J Obstet Gynecol Reprod Biol 2014;174:41-45
5. Froen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 2004;83:801-807
6. Cox P, Marton T. Pathological assessment of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2009;23:751-764
7. Barker DJ. The developmental origins of chronic adult disease. Acta Paediatr Suppl 2004;93:26-33
8. Wilhelm-Benartzi CS, Houseman EA, Maccani MA, Poage GM, Koestler DC, Langevin SM, Gagna LA, Banister CE, Padbury JF, Marsit CJ. In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta. Environ Health Perspect 2012;120:296-302
9. Sonderegger S, Pollheimer J, Knofler M. Wnt signalling in implantation, decidualisation and placental differentiation-review. Placenta 2010;31: 839-847
10. Ferreira JC, Choufani S, Grafodatskaya D, Butcher DT, Zhao C, Chitayat D, Shuman C, Kingdom J, Keating S, Weksberg R. WNT2 promoter methylation in human placenta is associated with low birthweight percentile in the neonate. Epigenetics 2011;64:440-449
11. Fowden AL, Sibley C, Reik W, Constancia M. Imprinted genes, placental development and fetal growth. Horm Res 2006;65:50-58
12. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W. Placentalspecific IGF-II is a major modulator of placental and fetal growth. Nature 2002;27;417:945-948
13. Weksberg R, Smith AC, Squire J, Sadowski P. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet 2003;12:R61-R68
14. Bartholdi D, Krajewska-Walasek M, Ounap K, Gaspar H, Chrzanowska KH, Ilyana H, Kayserili H, Lurie IW, Schinzel A, Baumer A. Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-Russell syndrome SRS: results from a large cohort of patients with SRS and SRS-like phenotypes. J Med Genet 2009;46:192-197
15. Koukoura O, Sifakis S, Soufla G, Zaravinos A, Apostolidou S, Jones A, Widschwendter M, Spandidos DA. Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restriction. Int J Mol Med 2011;28:481-487
16. Guo L, Choufani S, Ferreira J, Smith A, Chitayat D, Shuman C, Uxa R, Keating S, Kingdom J, Weksberg R. Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age SGA placentae. Dev Biol 2008;320:79-91
17. McMinn J, Wei M, Schupf N, Cusmai J, Johnson EB, Smith AC, Weksberg R, Thaker HM, Tycko B. Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta 2006;27:540-549
18. Tabano S, Colapietro P, Cetin I, Grati FR, Zanutto S, Mando C, Antonazzo P, Pileri P, Rossella F, Larizza L, Sirchia SM, Miozzo M. Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction. Epigenetics 2010;16(5):313-324
19. Chelbi ST, Mondon F, Jammes H, Buffat C, Mignot TM, Tost J, Busato F, Gut I, Rebourcet R, Laissue P, Tsatsaris V, Goffinet F, et al. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension 2007;49:76-83
20. Chelbi ST, Wilson ML, Veillard AC, Ingles SA, Zhang J, Mondon F, Gascoin-Lachambre G, Doridot L, Migrot TM, Rebourcet R, Carbonne B, Concordet JP. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet 2012;1;21:1968-1978
21. Blaise S, de Parseval N, Heidmann T. Functional characterization of two newly identified Human Endogenous Retrovirus coding envelope genes. Retrovirology 2005;14;2:19
22. Noorali S, Rotar IC, Lewis C, Pestaner JP, Pace DG, Sison A, Bagasra O. Role of HERV-W syncytin-1 in placentation and maintenance of human pregnancy. Appl Immunohistochem Mol Morphol 2009;17:319-328
23. Gao Y, He Z, Wang Z, Luo Y, Sun H, Zhou Y, Huang L, Li M, Fang Q, Jiang S. Increased expression and altered methylation of HERVWE1 in the human placentas of smaller fetuses from monozygotic, dichorionic, discordant twins. PLoS One 2012;7:e33503
24. Ruebner M, Strissel PL, Ekici AB, Stiegler E, Dammer U, Goecke TW, Faschingbauer F, Fahlbusch FB, Beckmann MW, Strick R. Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region. PLoS One 2013;8:e56145
25. Fournier T, Tsatsaris V, Handschuh K, Evain-Brion D. PPARs and the placenta. Placenta 2007;28:65-76
26. Schaiff WT, Barak Y, Sadovsky Y. The pleiotropic function of PPAR gamma in the placenta. Mol Cell Endocrinol 2006;249:10-15
27. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999;4:585-595
28. Diaz M, Bassols J, Lopez-Bermejo A, Gomez-Roig MD, de Zegher F, Ibanez L. Placental expression of peroxisome proliferator-activated receptor gamma (PPARgamma): relation to placental and fetal growth. J Clin Endocrinol Metab 2012;97:E1468-E1472
29. Prins JR, Faas MM, Melgert BN, Huitema S, Timmer A, Hylkema MN, Erwich JJ. Altered expression of immune-associated genes in firsttrimester human decidua of pregnancies later complicated with hypertension or foetal growth restriction. Placenta 2012;33:453-455
30. Huisman MA, Timmer B, Stegehuis J, Swart B, Aarnoudse JG, Erwich JH. Vascularization in first-trimester chorionic villi in complicated and uncomplicated pregnancies. Am J Obstet Gynecol 2010;202:88.e1-88.e7
31. Huisman MA, Timmer A, Zeinstra M, Serlier EK, Hanemaaijer R, Goor H, Erwich JJ. Matrix-metalloproteinase activity in first trimester placental bed biopsies in further complicated and uncomplicated pregnancies. Placenta 2004;25:253-258
32. Stichting Perinatale Registratie Nederland (PRN), Referentiecurven [Internet]. Utrecht, the Netherlands. http://www.perinatreg.nl/referentiecurven. Accessed 18 March 2012
33. Lin CC, Santolaya-Forgas J. Current concepts of fetal growth restriction: part I. Causes, classification, and pathophysiology. Obstet Gynecol 1998;92:1044-1055
34. Akiyama TFSEARCH. Searching Transcription Factor Binding Sites Ver 1.3 [Internet]. Parallel Application TRC Laboratory, RWCP, Japan. http://diyhpl.us/~bryan/irc/protocol-online/protocol-cache/TFSEARCH.html. Accessed 17 February 2013
35. Halford SE, Marko JF. How do site-specific DNA-binding proteins find their targets? Nucleic Acids Res 2004;3:3040-3052
36. Lee SA, Ding C. The dysfunctional placenta epigenome: causes and consequences. Epigenomics 2012;4:561-569
37. Banister CE, Koestler DC, Maccani MA, Padbury JF, Houseman EA, Marsit CJ. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics 2011;6:920-927
38. Cordeiro A, Neto AP, Carvalho F, Ramalho C, Dória S. Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes. J Assist Reprod Genet 2014;31:1361-1368
39. Marsit CJ, Maccani MA, Padbury JF, Bm. Lester. Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One 2012;7: e33794
40. Mulligan CJ, D'Errico NC, Stees J, Hughes DA. Methylation changes at NR3C1 in newborns associate with maternal prenatal stress exposure and newborn birth weight. Epigenetics 2012;7:853-857